Astressin-B
Astressin-B is a synthetic peptide that is known for its potential therapeutic applications in the field of gastroenterology and hair loss. It is a non-selective corticotropin-releasing hormone receptor antagonist.
History[edit | edit source]
Astressin-B was first synthesized and studied in the late 1990s. It was initially developed as a potential treatment for gastrointestinal disorders related to stress, due to its ability to block the effects of corticotropin-releasing hormone (CRH), a hormone that is released in response to stress.
Structure and Function[edit | edit source]
Astressin-B is a 33-amino acid peptide that acts as a non-selective antagonist for the corticotropin-releasing hormone receptor. This means it can bind to these receptors and prevent them from being activated by CRH. By blocking the effects of CRH, Astressin-B can potentially reduce the physiological responses to stress.
Therapeutic Applications[edit | edit source]
Gastroenterology[edit | edit source]
Astressin-B has been studied for its potential use in treating gastrointestinal disorders related to stress, such as irritable bowel syndrome (IBS). Stress can exacerbate the symptoms of IBS, and by blocking the effects of CRH, Astressin-B could potentially help to alleviate these symptoms.
Hair Loss[edit | edit source]
More recently, Astressin-B has been studied for its potential use in treating hair loss. In animal studies, it has been shown to promote hair growth in mice that had been genetically modified to overproduce CRH, suggesting that it could potentially be used to treat hair loss in humans.
Safety and Side Effects[edit | edit source]
As with any drug, the safety and potential side effects of Astressin-B are important considerations. While it has been shown to be safe in animal studies, further research is needed to determine its safety and potential side effects in humans.
Future Research[edit | edit source]
Future research on Astressin-B will likely focus on further exploring its potential therapeutic applications, particularly in the field of hair loss. More research is also needed to fully understand its mechanism of action and to determine the optimal dosage and administration method.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
